TopoTarget A/S of Denmark, whose founders and managers are clinical cancer specialists, has launched its first product on the US market. The product, Totect, is a treatment for patients who experience a specific type of accident during chemotherapy. ---Subscribe to MedNous to access this article--- Company News
